nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anemia is a poor prognostic factor for stage I non-small cell lung cancer (NSCLC) patients treated with Stereotactic Body Radiation Therapy (SBRT)
|
Pathak, Rima S. |
|
2019 |
16 |
C |
p. 28-33 |
artikel |
2 |
Comparison of the dose escalation potential for two hypofractionated radiotherapy regimens for locally advanced pancreatic cancer
|
Bertholet, Jenny |
|
2019 |
16 |
C |
p. 21-27 |
artikel |
3 |
Evaluation of organ motion-based robust optimisation for VMAT planning for breast and internal mammary chain radiotherapy
|
Dunlop, Alex |
|
2019 |
16 |
C |
p. 60-66 |
artikel |
4 |
Examining the Inter Hemispheric Transfer Time Test: A new computerized cognitive test to incorporate into therapeutic strategy for patients with brain metastases? A pilot study
|
Reygagne, Emmanuelle |
|
2019 |
16 |
C |
p. 48-54 |
artikel |
5 |
External validation of a prognostic score predicting overall survival for patients with brain metastases based on extracranial factors
|
Lewitzki, Victor |
|
2019 |
16 |
C |
p. 15-20 |
artikel |
6 |
Healthcare ex Machina: Are conversational agents ready for prime time in oncology?
|
Bibault, Jean-Emmanuel |
|
2019 |
16 |
C |
p. 55-59 |
artikel |
7 |
Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy
|
Linge, Annett |
|
2019 |
16 |
C |
p. 40-47 |
artikel |
8 |
The GIRAFE phase II trial on MVCT-based “volumes of the day” and “dose of the day” addresses when and how to implement adaptive radiotherapy for locally advanced head and neck cancer
|
Esteyrie, Vincent |
|
2019 |
16 |
C |
p. 34-39 |
artikel |
9 |
Treating the Chameleon: Radiotherapy in the management of Renal Cell Cancer
|
Tselis, Nikolaos |
|
2019 |
16 |
C |
p. 7-14 |
artikel |
10 |
Treatment of T3N0 non-small cell lung cancer with chest wall invasion using stereotactic body radiotherapy
|
Kennedy, William R. |
|
2019 |
16 |
C |
p. 1-6 |
artikel |